使成整体 发表于 2025-3-27 00:07:55

Kiwamu Okita (Professor and Chairman)Introducing the therapeutic modalities recently developed in Japan

Petechiae 发表于 2025-3-27 04:23:57

http://image.papertrans.cn/h/image/420172.jpg

GRAZE 发表于 2025-3-27 07:18:50

https://doi.org/10.1007/978-4-431-68488-6cancer; hepatitis; liver; liver disease; viral hepatitis; hepatology

藕床生厌倦 发表于 2025-3-27 12:21:48

http://reply.papertrans.cn/43/4202/420172/420172_34.png

植物学 发表于 2025-3-27 16:58:15

http://reply.papertrans.cn/43/4202/420172/420172_35.png

Criteria 发表于 2025-3-27 21:18:59

http://reply.papertrans.cn/43/4202/420172/420172_36.png

中子 发表于 2025-3-28 00:07:53

http://reply.papertrans.cn/43/4202/420172/420172_37.png

Unsaturated-Fat 发表于 2025-3-28 03:53:45

,Randomized Controlled Trial of Lymphoblastoid Interferon-α for Chronic Hepatitis C; Early Disappearase (ALT) levels and disappearance of hepatitis C virus (HCV) from serum continues for several years and probably permanently after IFN. Such a response is called sustained response, and has been thought to benefit the prognosis of the patients.

遗产 发表于 2025-3-28 08:36:45

http://reply.papertrans.cn/43/4202/420172/420172_39.png

terazosin 发表于 2025-3-28 13:34:01

mposium on Liver Disease, meeting in December 1998 and attended by leading hepatologists and virologists. Collected in this volume are the papers from the symposium, providing a valuable resource for hepatologists, gastroenterologists, and others working to understand and treat viral hepatitis.978-4-431-68490-9978-4-431-68488-6
页: 1 2 3 [4] 5
查看完整版本: Titlebook: HCV and Related Liver Diseases; Kiwamu Okita (Professor and Chairman) Conference proceedings 1999 Springer-Verlag Tokyo 1999 cancer.hepati